CEO Matt Walz to join investment panel and chair a Patient Recruitment track of the year’s most impactful summit focused on connecting clinical trial operations executives
CHAPEL HILL, NC and MALMO, SWEDEN – January XX, 2023 – Trialbee, the leader in data and technology-based patient recruitment and enrollment for clinical trials, will showcase its revolutionary Trialbee Honey™ clinical trial recruitment platform and participate in an expert investment panel at SCOPE Summit 2023 on February 6-9 in Orlando, FL.
Trialbee Honey is the leading enrollment performance platform for clinical trials. By using real-world data analytics to target recruitment and by medically pre-qualifying potential participants before they are referred to sites, Honey creates a single funnel of highly-targeted and pre-qualified participants that reduces site burden, simplifies the patient journey, and helps customers meet enrollment goals faster.
Honey’s Omnichannel referral capabilities enable organizations to streamline the experience for patients and sites from all recruitment sources and Honey’s Analytics model surfaces real-time insights on global recruitment activities and performance. To learn more, schedule a demo at www.trialbee.com.
The annual SCOPE Summit is the industry’s most impactful conference exclusively focused on connecting clinical trial operations executives who are actively seeking new technology to improve the experience for patients, sites, and study teams. Trialbee will actively contribute to critical conversations on the latest technology trends, recruitment targeting best practices, partnership channels, and more.
To engage with Trialbee at SCOPE…
– Go hands-on with live interactive demonstrations of Trialbee Honey at Exhibit Booth #113
– Attend the Clinical Trial Tech co-located conference to discuss the current state of investment with a distinguished panel of CEOs including Trialbee CEO Matt Walz on February 7 at 4:40pm
– Join the Patient Recruitment track to be chaired by Walz on February 8 at 9:10am – Network with patient recruitment subject matter experts including Maggie Adamski, Bill Abbott, Kyle Smith, Kyle Ashe, and Kristopher Sarajian
“SCOPE is a catalyst for innovation in our industry and Trialbee is excited to be a part of it,” said Walz. “While there are many impactful conferences, there’s something special about reconnecting with existing customers, meeting new partners, and most importantly learning from the many study team members, patient advocacy groups, and expert site staff who make SCOPE so engaging every year. And if you haven’t seen our Trialbee Honey platform lately, I can’t wait to get your feedback about what’s new – including indication-specific Omnichannel patient funnel tracking across all recruitment sources and partners.”
To learn more about Trialbee, visit Exhibit Booth #113 at SCOPE or www.trialbee.com.
Trialbee is the leading global data and technology platform for patient recruitment and enrollment in clinical trials. Trialbee Hive™ operationalizes real world data (RWD) and applies data science to find patients globally. Trialbee Honey™ simplifies the journey into clinical research for patients, reduces the burden of enrolling patients for sites and provides real-time, data-driven insights to sponsors and CROs
so they can optimize enrollment timelines. Partnering with sponsors, CROs, and virtual/decentralized sites and software providers, Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical trial populations. We are the smartest way to match and enroll patients for your clinical trial. For more information, visit http://www.trialbee.com or contact us at email@example.com.